Your browser doesn't support javascript.
loading
The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches.
Labrecque, Mark P; Alumkal, Joshi J; Coleman, Ilsa M; Nelson, Peter S; Morrissey, Colm.
Afiliación
  • Labrecque MP; Department of Urology, University of Washington School of Medicine, Seattle, Washington, USA.
  • Alumkal JJ; Department of Internal Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.
  • Coleman IM; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Nelson PS; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Morrissey C; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Endocr Relat Cancer ; 28(8): T51-T66, 2021 07 15.
Article en En | MEDLINE | ID: mdl-33792558

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Límite: Humans / Male Idioma: En Revista: Endocr Relat Cancer Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Límite: Humans / Male Idioma: En Revista: Endocr Relat Cancer Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos